ANTIHISTAMINE COLD CLAIMS TO BE REMOVED FROM UPCOMING FINAL MONOGRAPH, FDA SAYS; OTC ADVISORY CMTE.’s "PUBLIC SETTING" WILL FAVOR Rx-TO-OTC SWITCHES